| Symbol |
Name |
|
A2M
|
alpha-2-macroglobulin
|
|
AAGAB
|
alpha- and gamma-adaptin binding protein
|
|
AARS
|
alanyl-tRNA synthetase
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCA13
|
ATP-binding cassette, sub-family A (ABC1), member 13
|
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
|
ABCA7
|
ATP-binding cassette, sub-family A (ABC1), member 7
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB11
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11
|
|
ABCB4
|
ATP-binding cassette, sub-family B (MDR/TAP), member 4
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC11
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 11
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABCD1
|
ATP-binding cassette, sub-family D (ALD), member 1
|
|
ABCG1
|
ATP-binding cassette, sub-family G (WHITE), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABCG5
|
ATP-binding cassette, sub-family G (WHITE), member 5
|
|
ABCG8
|
ATP-binding cassette, sub-family G (WHITE), member 8
|
|
ABI3BP
|
ABI family, member 3 (NESH) binding protein
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABO
|
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
|
|
ACACB
|
acetyl-CoA carboxylase beta
|
|
ACAN
|
aggrecan
|
|
ACAT1
|
acetyl-CoA acetyltransferase 1
|
|
ACAT2
|
acetyl-CoA acetyltransferase 2
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACSL1
|
acyl-CoA synthetase long-chain family member 1
|
|
ACSL6
|
acyl-CoA synthetase long-chain family member 6
|
|
ACTN3
|
actinin, alpha 3 (gene/pseudogene)
|
|
ACTN4
|
actinin, alpha 4
|
|
ACVR1
|
activin A receptor, type I
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADA
|
adenosine deaminase
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM33
|
ADAM metallopeptidase domain 33
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAMTS5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
ADCY3
|
adenylate cyclase 3
|
|
ADD1
|
adducin 1 (alpha)
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
ADM
|
adrenomedullin
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADRA1A
|
adrenoceptor alpha 1A
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
ADSS
|
adenylosuccinate synthase
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AGXT
|
alanine-glyoxylate aminotransferase
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AIRE
|
autoimmune regulator
|
|
AKAP10
|
A kinase (PRKA) anchor protein 10
|
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase)
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
ALDH1A2
|
aldehyde dehydrogenase 1 family, member A2
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALDH7A1
|
aldehyde dehydrogenase 7 family, member A1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALMS1
|
Alstrom syndrome protein 1
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALOX5AP
|
arachidonate 5-lipoxygenase-activating protein
|
|
ALPK1
|
alpha-kinase 1
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
AMELY
|
amelogenin, Y-linked
|
|
AMH
|
anti-Mullerian hormone
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANGPTL4
|
angiopoietin-like 4
|
|
ANKH
|
ANKH inorganic pyrophosphate transport regulator
|
|
ANTXR2
|
anthrax toxin receptor 2
|
|
ANXA5
|
annexin A5
|
|
AOAH
|
acyloxyacyl hydrolase (neutrophil)
|
|
AP3S1
|
adaptor-related protein complex 3, sigma 1 subunit
|
|
APBA2
|
amyloid beta (A4) precursor protein-binding, family A, member 2
|
|
APC
|
adenomatous polyposis coli
|
|
APCDD1
|
adenomatosis polyposis coli down-regulated 1
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APLN
|
apelin
|
|
APLNR
|
apelin receptor
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA4
|
apolipoprotein A-IV
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOBEC3B
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B
|
|
APOBEC3F
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOC1
|
apolipoprotein C-I
|
|
APOC2
|
apolipoprotein C-II
|
|
APOC3
|
apolipoprotein C-III
|
|
APOE
|
apolipoprotein E
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APOL1
|
apolipoprotein L, 1
|
|
APOL6
|
apolipoprotein L, 6
|
|
APOM
|
apolipoprotein M
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
APPL1
|
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1
|
|
APPL2
|
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
AQP4
|
aquaporin 4
|
|
AQP5
|
aquaporin 5
|
|
AR
|
androgen receptor
|
|
ARG1
|
arginase 1
|
|
ARHGAP4
|
Rho GTPase activating protein 4
|
|
ARHGEF10
|
Rho guanine nucleotide exchange factor (GEF) 10
|
|
ARHGEF11
|
Rho guanine nucleotide exchange factor (GEF) 11
|
|
ARHGEF28
|
Rho guanine nucleotide exchange factor (GEF) 28
|
|
ARHGEF3
|
Rho guanine nucleotide exchange factor (GEF) 3
|
|
ARID5B
|
AT rich interactive domain 5B (MRF1-like)
|
|
ARL6IP5
|
ADP-ribosylation factor-like 6 interacting protein 5
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
|
AS3MT
|
arsenite methyltransferase
|
|
ASAH1
|
N-acylsphingosine amidohydrolase (acid ceramidase) 1
|
|
ASIC1
|
acid sensing (proton gated) ion channel 1
|
|
ASPN
|
asporin
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
ATF6
|
activating transcription factor 6
|
|
ATG10
|
autophagy related 10
|
|
ATG5
|
autophagy related 5
|
|
ATL1
|
atlastin GTPase 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP13A2
|
ATPase type 13A2
|
|
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide
|
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide
|
|
ATP1B4
|
ATPase, Na+/K+ transporting, beta 4 polypeptide
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
ATP2B1
|
ATPase, Ca++ transporting, plasma membrane 1
|
|
ATP2B2
|
ATPase, Ca++ transporting, plasma membrane 2
|
|
ATP2C1
|
ATPase, Ca++ transporting, type 2C, member 1
|
|
ATP6V0A4
|
ATPase, H+ transporting, lysosomal V0 subunit a4
|
|
ATP7A
|
ATPase, Cu++ transporting, alpha polypeptide
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATP8B1
|
ATPase, aminophospholipid transporter, class I, type 8B, member 1
|
|
ATPIF1
|
ATPase inhibitory factor 1
|
|
ATXN10
|
ataxin 10
|
|
ATXN2
|
ataxin 2
|
|
ATXN3
|
ataxin 3
|
|
ATXN7
|
ataxin 7
|
|
AURKA
|
aurora kinase A
|
|
AVP
|
arginine vasopressin
|
|
AVPR2
|
arginine vasopressin receptor 2
|
|
AXIN2
|
axin 2
|
|
AZF1
|
azoospermia factor 1
|
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding
|
|
AZIN1
|
antizyme inhibitor 1
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BACE2
|
beta-site APP-cleaving enzyme 2
|
|
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BANK1
|
B-cell scaffold protein with ankyrin repeats 1
|
|
BAX
|
BCL2-associated X protein
|
|
BBS7
|
Bardet-Biedl syndrome 7
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCL9
|
B-cell CLL/lymphoma 9
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BEAN1
|
brain expressed, associated with NEDD4, 1
|
|
BEST1
|
bestrophin 1
|
|
BFSP1
|
beaded filament structural protein 1, filensin
|
|
BFSP2
|
beaded filament structural protein 2, phakinin
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BLID
|
BH3-like motif containing, cell death inducer
|
|
BLK
|
BLK proto-oncogene, Src family tyrosine kinase
|
|
BMP15
|
bone morphogenetic protein 15
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP3
|
bone morphogenetic protein 3
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BMP8B
|
bone morphogenetic protein 8b
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BPIFA1
|
BPI fold containing family A, member 1
|
|
BPY2
|
basic charge, Y-linked, 2
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRAP
|
BRCA1 associated protein
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRIP1
|
BRCA1 interacting protein C-terminal helicase 1
|
|
BST1
|
bone marrow stromal cell antigen 1
|
|
BTD
|
biotinidase
|
|
BTLA
|
B and T lymphocyte associated
|
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
|
C10ORF2
|
chromosome 10 open reading frame 2
|
|
C1GALT1
|
core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1
|
|
C1GALT1C1
|
C1GALT1-specific chaperone 1
|
|
C1QA
|
complement component 1, q subcomponent, A chain
|
|
C2
|
complement component 2
|
|
C3
|
complement component 3
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
|
C4B
|
complement component 4B (Chido blood group)
|
|
C5
|
complement component 5
|
|
C5AR2
|
complement component 5a receptor 2
|
|
C6ORF48
|
chromosome 6 open reading frame 48
|
|
C9ORF72
|
chromosome 9 open reading frame 72
|
|
CABIN1
|
calcineurin binding protein 1
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CACNA1G
|
calcium channel, voltage-dependent, T type, alpha 1G subunit
|
|
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit
|
|
CACNA1S
|
calcium channel, voltage-dependent, L type, alpha 1S subunit
|
|
CACNB2
|
calcium channel, voltage-dependent, beta 2 subunit
|
|
CALHM1
|
calcium homeostasis modulator 1
|
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
|
CALR
|
calreticulin
|
|
CAMK1G
|
calcium/calmodulin-dependent protein kinase IG
|
|
CAMKK1
|
calcium/calmodulin-dependent protein kinase kinase 1, alpha
|
|
CAMSAP2
|
calmodulin regulated spectrin-associated protein family, member 2
|
|
CAMSAP3
|
calmodulin regulated spectrin-associated protein family, member 3
|
|
CAPN10
|
calpain 10
|
|
CAPN3
|
calpain 3, (p94)
|
|
CARD14
|
caspase recruitment domain family, member 14
|
|
CARD9
|
caspase recruitment domain family, member 9
|
|
CASP10
|
caspase 10, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAST
|
calpastatin
|
|
CAT
|
catalase
|
|
CBR3
|
carbonyl reductase 3
|
|
CC2D1A
|
coiled-coil and C2 domain containing 1A
|
|
CC2D2A
|
coiled-coil and C2 domain containing 2A
|
|
CCDC26
|
CCDC26 long non-coding RNA
|
|
CCDC62
|
coiled-coil domain containing 62
|
|
CCK
|
cholecystokinin
|
|
CCKAR
|
cholecystokinin A receptor
|
|
CCL19
|
chemokine (C-C motif) ligand 19
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCL8
|
chemokine (C-C motif) ligand 8
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCNE1
|
cyclin E1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CCRN4L
|
CCR4 carbon catabolite repression 4-like (S. cerevisiae)
|
|
CD14
|
CD14 molecule
|
|
CD164L2
|
CD164 sialomucin-like 2
|
|
CD2
|
CD2 molecule
|
|
CD209
|
CD209 molecule
|
|
CD226
|
CD226 molecule
|
|
CD27
|
CD27 molecule
|
|
CD28
|
CD28 molecule
|
|
CD33
|
CD33 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD38
|
CD38 molecule
|
|
CD3EAP
|
CD3e molecule, epsilon associated protein
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD70
|
CD70 molecule
|
|
CD72
|
CD72 molecule
|
|
CD86
|
CD86 molecule
|
|
CDA
|
cytidine deaminase
|
|
CDAN1
|
codanin 1
|
|
CDC73
|
cell division cycle 73
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH17
|
cadherin 17, LI cadherin (liver-intestine)
|
|
CDH23
|
cadherin-related 23
|
|
CDH7
|
cadherin 7, type 2
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK11A
|
cyclin-dependent kinase 11A
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK5RAP2
|
CDK5 regulatory subunit associated protein 2
|
|
CDKAL1
|
CDK5 regulatory subunit associated protein 1-like 1
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDX2
|
caudal type homeobox 2
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CES1P1
|
carboxylesterase 1 pseudogene 1
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFB
|
complement factor B
|
|
CFC1
|
cripto, FRL-1, cryptic family 1
|
|
CFH
|
complement factor H
|
|
CFHR1
|
complement factor H-related 1
|
|
CFHR3
|
complement factor H-related 3
|
|
CFI
|
complement factor I
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHGB
|
chromogranin B
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHKB
|
choline kinase beta
|
|
CHL1
|
cell adhesion molecule L1-like
|
|
CHM
|
choroideremia (Rab escort protein 1)
|
|
CHN2
|
chimerin 2
|
|
CHRM1
|
cholinergic receptor, muscarinic 1
|
|
CHRNA2
|
cholinergic receptor, nicotinic, alpha 2 (neuronal)
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal)
|
|
CHRNA6
|
cholinergic receptor, nicotinic, alpha 6 (neuronal)
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CHRNB2
|
cholinergic receptor, nicotinic, beta 2 (neuronal)
|
|
CHRNB3
|
cholinergic receptor, nicotinic, beta 3 (neuronal)
|
|
CHRNG
|
cholinergic receptor, nicotinic, gamma (muscle)
|
|
CHST6
|
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6
|
|
CIDEA
|
cell death-inducing DFFA-like effector a
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CILP
|
cartilage intermediate layer protein, nucleotide pyrophosphohydrolase
|
|
CISH
|
cytokine inducible SH2-containing protein
|
|
CKM
|
creatine kinase, muscle
|
|
CLCA1
|
chloride channel accessory 1
|
|
CLCN5
|
chloride channel, voltage-sensitive 5
|
|
CLCN7
|
chloride channel, voltage-sensitive 7
|
|
CLDN5
|
claudin 5
|
|
CLEC16A
|
C-type lectin domain family 16, member A
|
|
CLEC4M
|
C-type lectin domain family 4, member M
|
|
CLIC4
|
chloride intracellular channel 4
|
|
CLOCK
|
clock circadian regulator
|
|
CLPTM1L
|
CLPTM1-like
|
|
CLU
|
clusterin
|
|
CMA1
|
chymase 1, mast cell
|
|
CMYA5
|
cardiomyopathy associated 5
|
|
CNDP1
|
carnosine dipeptidase 1 (metallopeptidase M20 family)
|
|
CNGA3
|
cyclic nucleotide gated channel alpha 3
|
|
CNP
|
2',3'-cyclic nucleotide 3' phosphodiesterase
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
CNTNAP2
|
contactin associated protein-like 2
|
|
CNTROB
|
centrobin, centrosomal BRCA2 interacting protein
|
|
COCH
|
cochlin
|
|
COL11A1
|
collagen, type XI, alpha 1
|
|
COL17A1
|
collagen, type XVII, alpha 1
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COL4A3
|
collagen, type IV, alpha 3 (Goodpasture antigen)
|
|
COL4A5
|
collagen, type IV, alpha 5
|
|
COL6A1
|
collagen, type VI, alpha 1
|
|
COL6A2
|
collagen, type VI, alpha 2
|
|
COL6A3
|
collagen, type VI, alpha 3
|
|
COL6A4P1
|
collagen, type VI, alpha 4 pseudogene 1
|
|
COL7A1
|
collagen, type VII, alpha 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
CP
|
ceruloplasmin (ferroxidase)
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CPE
|
carboxypeptidase E
|
|
CPSF4
|
cleavage and polyadenylation specific factor 4, 30kDa
|
|
CPT1B
|
carnitine palmitoyltransferase 1B (muscle)
|
|
CPT2
|
carnitine palmitoyltransferase 2
|
|
CPVL
|
carboxypeptidase, vitellogenic-like
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CRB1
|
crumbs family member 1, photoreceptor morphogenesis associated
|
|
CREG1
|
cellular repressor of E1A-stimulated genes 1
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRHR2
|
corticotropin releasing hormone receptor 2
|
|
CRISPLD2
|
cysteine-rich secretory protein LCCL domain containing 2
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTC3
|
CREB regulated transcription coactivator 3
|
|
CRY1
|
cryptochrome circadian clock 1
|
|
CRYAA
|
crystallin, alpha A
|
|
CRYAB
|
crystallin, alpha B
|
|
CRYBA1
|
crystallin, beta A1
|
|
CRYBB1
|
crystallin, beta B1
|
|
CRYBB2
|
crystallin, beta B2
|
|
CRYGC
|
crystallin, gamma C
|
|
CRYGD
|
crystallin, gamma D
|
|
CRYGS
|
crystallin, gamma S
|
|
CSF2RB
|
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)
|
|
CSK
|
c-src tyrosine kinase
|
|
CSNK1E
|
casein kinase 1, epsilon
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CSNK2B
|
casein kinase 2, beta polypeptide
|
|
CST3
|
cystatin C
|
|
CTGF
|
connective tissue growth factor
|
|
CTH
|
cystathionine gamma-lyase
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNND2
|
catenin (cadherin-associated protein), delta 2
|
|
CTRC
|
chymotrypsin C (caldecrin)
|
|
CTSC
|
cathepsin C
|
|
CTSS
|
cathepsin S
|
|
CUBN
|
cubilin (intrinsic factor-cobalamin receptor)
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL14
|
chemokine (C-X-C motif) ligand 14
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYB5R3
|
cytochrome b5 reductase 3
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
|
CYP11B1
|
cytochrome P450, family 11, subfamily B, polypeptide 1
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP27A1
|
cytochrome P450, family 27, subfamily A, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2A13
|
cytochrome P450, family 2, subfamily A, polypeptide 13
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2
|
|
CYP3A
|
cytochrome P450, family 3, subfamily A
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
CYP3A7
|
cytochrome P450, family 3, subfamily A, polypeptide 7
|
|
CYP46A1
|
cytochrome P450, family 46, subfamily A, polypeptide 1
|
|
CYP4A11
|
cytochrome P450, family 4, subfamily A, polypeptide 11
|
|
CYP4F2
|
cytochrome P450, family 4, subfamily F, polypeptide 2
|
|
CYP4V2
|
cytochrome P450, family 4, subfamily V, polypeptide 2
|
|
CYP7B1
|
cytochrome P450, family 7, subfamily B, polypeptide 1
|
|
CYP8B1
|
cytochrome P450, family 8, subfamily B, polypeptide 1
|
|
CYSLTR1
|
cysteinyl leukotriene receptor 1
|
|
CYSLTR2
|
cysteinyl leukotriene receptor 2
|
|
DAB1
|
Dab, reelin signal transducer, homolog 1 (Drosophila)
|
|
DACH1
|
dachshund family transcription factor 1
|
|
DACT1
|
dishevelled-binding antagonist of beta-catenin 1
|
|
DAO
|
D-amino-acid oxidase
|
|
DAOA
|
D-amino acid oxidase activator
|
|
DAOA-AS1
|
DAOA antisense RNA 1
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DAZ1
|
deleted in azoospermia 1
|
|
DAZ2
|
deleted in azoospermia 2
|
|
DAZL
|
deleted in azoospermia-like
|
|
DCANP1
|
dendritic cell-associated nuclear protein
|
|
DCDC2
|
doublecortin domain containing 2
|
|
DCK
|
deoxycytidine kinase
|
|
DCN
|
decorin
|
|
DCT
|
dopachrome tautomerase
|
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1
|
|
DDX43
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 43
|
|
DEFA1A3
|
defensin, alpha 1 and alpha 3, variable copy number locus
|
|
DEFB1
|
defensin, beta 1
|
|
DENND1A
|
DENN/MADD domain containing 1A
|
|
DES
|
desmin
|
|
DFNA53
|
deafness, autosomal dominant 53
|
|
DFNB59
|
deafness, autosomal recessive 59
|
|
DGAT2
|
diacylglycerol O-acyltransferase 2
|
|
DGKD
|
diacylglycerol kinase, delta 130kDa
|
|
DGKH
|
diacylglycerol kinase, eta
|
|
DGKQ
|
diacylglycerol kinase, theta 110kDa
|
|
DHCR7
|
7-dehydrocholesterol reductase
|
|
DHTKD1
|
dehydrogenase E1 and transketolase domain containing 1
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DKC1
|
dyskeratosis congenita 1, dyskerin
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DKK4
|
dickkopf WNT signaling pathway inhibitor 4
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DLG3
|
discs, large homolog 3 (Drosophila)
|
|
DLG4
|
discs, large homolog 4 (Drosophila)
|
|
DLX1
|
distal-less homeobox 1
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DMC1
|
DNA meiotic recombinase 1
|
|
DMD
|
dystrophin
|
|
DNAH5
|
dynein, axonemal, heavy chain 5
|
|
DNAJC13
|
DnaJ (Hsp40) homolog, subfamily C, member 13
|
|
DNAJC5
|
DnaJ (Hsp40) homolog, subfamily C, member 5
|
|
DNAJC6
|
DnaJ (Hsp40) homolog, subfamily C, member 6
|
|
DNASE1
|
deoxyribonuclease I
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DPH5
|
diphthamide biosynthesis 5
|
|
DPP10
|
dipeptidyl-peptidase 10 (non-functional)
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPP6
|
dipeptidyl-peptidase 6
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DRD3
|
dopamine receptor D3
|
|
DRD4
|
dopamine receptor D4
|
|
DRD5
|
dopamine receptor D5
|
|
DROSHA
|
drosha, ribonuclease type III
|
|
DSCAM
|
Down syndrome cell adhesion molecule
|
|
DSPP
|
dentin sialophosphoprotein
|
|
DTNBP1
|
dystrobrevin binding protein 1
|
|
DUSP10
|
dual specificity phosphatase 10
|
|
DUSP12
|
dual specificity phosphatase 12
|
|
DUSP6
|
dual specificity phosphatase 6
|
|
DYSF
|
dysferlin
|
|
DYX1C1
|
dyslexia susceptibility 1 candidate 1
|
|
EBI3
|
Epstein-Barr virus induced 3
|
|
ECE1
|
endothelin converting enzyme 1
|
|
ECM1
|
extracellular matrix protein 1
|
|
EDA
|
ectodysplasin A
|
|
EDA2R
|
ectodysplasin A2 receptor
|
|
EDAR
|
ectodysplasin A receptor
|
|
EDARADD
|
EDAR-associated death domain
|
|
EDN1
|
endothelin 1
|
|
EDN3
|
endothelin 3
|
|
EDNRB
|
endothelin receptor type B
|
|
EFNA1
|
ephrin-A1
|
|
EFNB2
|
ephrin-B2
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN2
|
egl-9 family hypoxia-inducible factor 2
|
|
EGR1
|
early growth response 1
|
|
EGR3
|
early growth response 3
|
|
EIF2AK4
|
eukaryotic translation initiation factor 2 alpha kinase 4
|
|
EIF2B4
|
eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa
|
|
EIF2B5
|
eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
ELF1
|
E74-like factor 1 (ets domain transcription factor)
|
|
ELMO1
|
engulfment and cell motility 1
|
|
ELN
|
elastin
|
|
ELOVL2
|
ELOVL fatty acid elongase 2
|
|
ELOVL4
|
ELOVL fatty acid elongase 4
|
|
EML4
|
echinoderm microtubule associated protein like 4
|
|
EN2
|
engrailed homeobox 2
|
|
ENAM
|
enamelin
|
|
ENG
|
endoglin
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA2
|
EPH receptor A2
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
ERAP1
|
endoplasmic reticulum aminopeptidase 1
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC4
|
excision repair cross-complementation group 4
|
|
ERCC5
|
excision repair cross-complementation group 5
|
|
ERCC6
|
excision repair cross-complementation group 6
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETFDH
|
electron-transferring-flavoprotein dehydrogenase
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
EXO1
|
exonuclease 1
|
|
EXOC3L2
|
exocyst complex component 3-like 2
|
|
EXT1
|
exostosin glycosyltransferase 1
|
|
EXT2
|
exostosin glycosyltransferase 2
|
|
EYS
|
eyes shut homolog (Drosophila)
|
|
EZR
|
ezrin
|
|
F10
|
coagulation factor X
|
|
F11
|
coagulation factor XI
|
|
F11R
|
F11 receptor
|
|
F12
|
coagulation factor XII (Hageman factor)
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
F9
|
coagulation factor IX
|
|
FA2H
|
fatty acid 2-hydroxylase
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FABP1
|
fatty acid binding protein 1, liver
|
|
FABP2
|
fatty acid binding protein 2, intestinal
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FABP5
|
fatty acid binding protein 5 (psoriasis-associated)
|
|
FADS1
|
fatty acid desaturase 1
|
|
FADS2
|
fatty acid desaturase 2
|
|
FAH
|
fumarylacetoacetate hydrolase (fumarylacetoacetase)
|
|
FAIM2
|
Fas apoptotic inhibitory molecule 2
|
|
FAM13A
|
family with sequence similarity 13, member A
|
|
FAM167A
|
family with sequence similarity 167, member A
|
|
FAM46A
|
family with sequence similarity 46, member A
|
|
FAR1
|
fatty acyl CoA reductase 1
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBN1
|
fibrillin 1
|
|
FBN3
|
fibrillin 3
|
|
FBXO7
|
F-box protein 7
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
|
FCN2
|
ficolin (collagen/fibrinogen domain containing lectin) 2
|
|
FCN3
|
ficolin (collagen/fibrinogen domain containing) 3
|
|
FCRL3
|
Fc receptor-like 3
|
|
FCRL4
|
Fc receptor-like 4
|
|
FCRLB
|
Fc receptor-like B
|
|
FECH
|
ferrochelatase
|
|
FEM1A
|
fem-1 homolog a (C. elegans)
|
|
FGA
|
fibrinogen alpha chain
|
|
FGB
|
fibrinogen beta chain
|
|
FGD1
|
FYVE, RhoGEF and PH domain containing 1
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF10
|
fibroblast growth factor 10
|
|
FGF14
|
fibroblast growth factor 14
|
|
FGF18
|
fibroblast growth factor 18
|
|
FGF19
|
fibroblast growth factor 19
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF20
|
fibroblast growth factor 20
|
|
FGF21
|
fibroblast growth factor 21
|
|
FGF4
|
fibroblast growth factor 4
|
|
FGF5
|
fibroblast growth factor 5
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FGGY
|
FGGY carbohydrate kinase domain containing
|
|
FHIT
|
fragile histidine triad
|
|
FIGLA
|
folliculogenesis specific basic helix-loop-helix
|
|
FKBP6
|
FK506 binding protein 6, 36kDa
|
|
FKRP
|
fukutin related protein
|
|
FLG
|
filaggrin
|
|
FLNC
|
filamin C, gamma
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FNDC5
|
fibronectin type III domain containing 5
|
|
FOLR1
|
folate receptor 1 (adult)
|
|
FOXE1
|
forkhead box E1
|
|
FOXH1
|
forkhead box H1
|
|
FOXL2
|
forkhead box L2
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP2
|
forkhead box P2
|
|
FOXP3
|
forkhead box P3
|
|
FPGS
|
folylpolyglutamate synthase
|
|
FPR2
|
formyl peptide receptor 2
|
|
FRMD7
|
FERM domain containing 7
|
|
FRZB
|
frizzled-related protein
|
|
FSCN2
|
fascin actin-bundling protein 2, retinal
|
|
FSHB
|
follicle stimulating hormone, beta polypeptide
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FST
|
follistatin
|
|
FTL
|
ferritin, light polypeptide
|
|
FTO
|
fat mass and obesity associated
|
|
FTSJ1
|
FtsJ RNA methyltransferase homolog 1 (E. coli)
|
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
|
FUS
|
FUS RNA binding protein
|
|
FUT1
|
fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group)
|
|
FUT2
|
fucosyltransferase 2 (secretor status included)
|
|
FXYD6
|
FXYD domain containing ion transport regulator 6
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
FZD3
|
frizzled class receptor 3
|
|
FZD4
|
frizzled class receptor 4
|
|
G6PC
|
glucose-6-phosphatase, catalytic subunit
|
|
G6PC2
|
glucose-6-phosphatase, catalytic, 2
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAA
|
glucosidase, alpha; acid
|
|
GAB2
|
GRB2-associated binding protein 2
|
|
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1
|
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1
|
|
GABRA6
|
gamma-aminobutyric acid (GABA) A receptor, alpha 6
|
|
GABRB2
|
gamma-aminobutyric acid (GABA) A receptor, beta 2
|
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3
|
|
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2
|
|
GAD1
|
glutamate decarboxylase 1 (brain, 67kDa)
|
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
|
GADL1
|
glutamate decarboxylase-like 1
|
|
GAK
|
cyclin G associated kinase
|
|
GAL
|
galanin/GMAP prepropeptide
|
|
GALC
|
galactosylceramidase
|
|
GALNT3
|
polypeptide N-acetylgalactosaminyltransferase 3
|
|
GATA3
|
GATA binding protein 3
|
|
GATA4
|
GATA binding protein 4
|
|
GBA
|
glucosidase, beta, acid
|
|
GC
|
group-specific component (vitamin D binding protein)
|
|
GCG
|
glucagon
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GCKR
|
glucokinase (hexokinase 4) regulator
|
|
GCLC
|
glutamate-cysteine ligase, catalytic subunit
|
|
GCLM
|
glutamate-cysteine ligase, modifier subunit
|
|
GDF1
|
growth differentiation factor 1
|
|
GDF15
|
growth differentiation factor 15
|
|
GDF5
|
growth differentiation factor 5
|
|
GDF9
|
growth differentiation factor 9
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GGCX
|
gamma-glutamyl carboxylase
|
|
GGH
|
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)
|
|
GGT1
|
gamma-glutamyltransferase 1
|
|
GH1
|
growth hormone 1
|
|
GHR
|
growth hormone receptor
|
|
GHRH
|
growth hormone releasing hormone
|
|
GHRHR
|
growth hormone releasing hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GIGYF2
|
GRB10 interacting GYF protein 2
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJA3
|
gap junction protein, alpha 3, 46kDa
|
|
GJA4
|
gap junction protein, alpha 4, 37kDa
|
|
GJA8
|
gap junction protein, alpha 8, 50kDa
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GJB3
|
gap junction protein, beta 3, 31kDa
|
|
GJB4
|
gap junction protein, beta 4, 30.3kDa
|
|
GJB6
|
gap junction protein, beta 6, 30kDa
|
|
GJC2
|
gap junction protein, gamma 2, 47kDa
|
|
GLA
|
galactosidase, alpha
|
|
GLB1
|
galactosidase, beta 1
|
|
GLI3
|
GLI family zinc finger 3
|
|
GLIS1
|
GLIS family zinc finger 1
|
|
GLO1
|
glyoxalase I
|
|
GLUD1
|
glutamate dehydrogenase 1
|
|
GNAL
|
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNAS
|
GNAS complex locus
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GNE
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase
|
|
GNPTG
|
N-acetylglucosamine-1-phosphate transferase, gamma subunit
|
|
GOLM1
|
golgi membrane protein 1
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GPI
|
glucose-6-phosphate isomerase
|
|
GPR143
|
G protein-coupled receptor 143
|
|
GPR174
|
G protein-coupled receptor 174
|
|
GPR3
|
G protein-coupled receptor 3
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
|
GPX1
|
glutathione peroxidase 1
|
|
GPX3
|
glutathione peroxidase 3
|
|
GPX4
|
glutathione peroxidase 4
|
|
GREB1
|
growth regulation by estrogen in breast cancer 1
|
|
GREM2
|
gremlin 2, DAN family BMP antagonist
|
|
GRHL2
|
grainyhead-like 2 (Drosophila)
|
|
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GRK4
|
G protein-coupled receptor kinase 4
|
|
GRK5
|
G protein-coupled receptor kinase 5
|
|
GRK6
|
G protein-coupled receptor kinase 6
|
|
GRM3
|
glutamate receptor, metabotropic 3
|
|
GRM7
|
glutamate receptor, metabotropic 7
|
|
GRN
|
granulin
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTM3
|
glutathione S-transferase mu 3 (brain)
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GUCA1A
|
guanylate cyclase activator 1A (retina)
|
|
GUCY1B3
|
guanylate cyclase 1, soluble, beta 3
|
|
GUCY2D
|
guanylate cyclase 2D, membrane (retina-specific)
|
|
H2BFWT
|
H2B histone family, member W, testis-specific
|
|
HADHB
|
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit
|
|
HAND1
|
heart and neural crest derivatives expressed 1
|
|
HAS2
|
hyaluronan synthase 2
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HAX1
|
HCLS1 associated protein X-1
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HBA2
|
hemoglobin, alpha 2
|
|
HBB
|
hemoglobin, beta
|
|
HBE1
|
hemoglobin, epsilon 1
|
|
HCRT
|
hypocretin (orexin) neuropeptide precursor
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HDAC9
|
histone deacetylase 9
|
|
HDC
|
histidine decarboxylase
|
|
HES7
|
hes family bHLH transcription factor 7
|
|
HFE
|
hemochromatosis
|
|
HFM1
|
HFM1, ATP-dependent DNA helicase homolog (S. cerevisiae)
|
|
HGD
|
homogentisate 1,2-dioxygenase
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HHEX
|
hematopoietically expressed homeobox
|
|
HHIP
|
hedgehog interacting protein
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HINT1
|
histidine triad nucleotide binding protein 1
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DMA
|
major histocompatibility complex, class II, DM alpha
|
|
HLA-DMB
|
major histocompatibility complex, class II, DM beta
|
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRA
|
major histocompatibility complex, class II, DR alpha
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HLCS
|
holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase)
|
|
HMBS
|
hydroxymethylbilane synthase
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
HMGN3
|
high mobility group nucleosomal binding domain 3
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNMT
|
histamine N-methyltransferase
|
|
HOMEZ
|
homeobox and leucine zipper encoding
|
|
HORMAD2
|
HORMA domain containing 2
|
|
HOXA11
|
homeobox A11
|
|
HOXB13
|
homeobox B13
|
|
HOXB9
|
homeobox B9
|
|
HOXC9
|
homeobox C9
|
|
HOXD13
|
homeobox D13
|
|
HOXD4
|
homeobox D4
|
|
HOXD9
|
homeobox D9
|
|
HP
|
haptoglobin
|
|
HPDL
|
4-hydroxyphenylpyruvate dioxygenase-like
|
|
HPS1
|
Hermansky-Pudlak syndrome 1
|
|
HR
|
hair growth associated
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRH4
|
histamine receptor H4
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSD17B3
|
hydroxysteroid (17-beta) dehydrogenase 3
|
|
HSD17B6
|
hydroxysteroid (17-beta) dehydrogenase 6
|
|
HSD3B1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
|
|
HSF4
|
heat shock transcription factor 4
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA1B
|
heat shock 70kDa protein 1B
|
|
HSPA2
|
heat shock 70kDa protein 2
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPB8
|
heat shock 22kDa protein 8
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
|
HTR1D
|
5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled
|
|
HTR1F
|
5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
HTR3A
|
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
HTT
|
huntingtin
|
|
HULC
|
hepatocellular carcinoma up-regulated long non-coding RNA
|
|
HYAL3
|
hyaluronoglucosaminidase 3
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICAM4
|
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
IDE
|
insulin-degrading enzyme
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDS
|
iduronate 2-sulfatase
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFITM3
|
interferon induced transmembrane protein 3
|
|
IFITM5
|
interferon induced transmembrane protein 5
|
|
IFNG
|
interferon, gamma
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IFNGR2
|
interferon gamma receptor 2 (interferon gamma transducer 1)
|
|
IFNL3
|
interferon, lambda 3
|
|
IFRD1
|
interferon-related developmental regulator 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP4
|
insulin-like growth factor binding protein 4
|
|
IGH
|
immunoglobulin heavy locus
|
|
IGHA1
|
immunoglobulin heavy constant alpha 1
|
|
IGHMBP2
|
immunoglobulin mu binding protein 2
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL10
|
interleukin 10
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL12RB1
|
interleukin 12 receptor, beta 1
|
|
IL13
|
interleukin 13
|
|
IL15
|
interleukin 15
|
|
IL16
|
interleukin 16
|
|
IL17A
|
interleukin 17A
|
|
IL17F
|
interleukin 17F
|
|
IL17RC
|
interleukin 17 receptor C
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R2
|
interleukin 1 receptor, type II
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL20
|
interleukin 20
|
|
IL21
|
interleukin 21
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL23R
|
interleukin 23 receptor
|
|
IL27
|
interleukin 27
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL2RB
|
interleukin 2 receptor, beta
|
|
IL3
|
interleukin 3
|
|
IL33
|
interleukin 33
|
|
IL36RN
|
interleukin 36 receptor antagonist
|
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL5RA
|
interleukin 5 receptor, alpha
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL7R
|
interleukin 7 receptor
|
|
INHBA
|
inhibin, beta A
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
|
INS
|
insulin
|
|
INSIG2
|
insulin induced gene 2
|
|
INSR
|
insulin receptor
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
IREB2
|
iron-responsive element binding protein 2
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRF6
|
interferon regulatory factor 6
|
|
IRS1
|
insulin receptor substrate 1
|
|
ISL1
|
ISL LIM homeobox 1
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA9
|
integrin, alpha 9
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITIH1
|
inter-alpha-trypsin inhibitor heavy chain 1
|
|
ITK
|
IL2-inducible T-cell kinase
|
|
ITLN1
|
intelectin 1 (galactofuranose binding)
|
|
ITPA
|
inosine triphosphatase (nucleoside triphosphate pyrophosphatase)
|
|
ITPKC
|
inositol-trisphosphate 3-kinase C
|
|
ITPR2
|
inositol 1,4,5-trisphosphate receptor, type 2
|
|
IVD
|
isovaleryl-CoA dehydrogenase
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JMY
|
junction mediating and regulatory protein, p53 cofactor
|
|
KCND3
|
potassium channel, voltage gated Shal related subfamily D, member 3
|
|
KCNE1
|
potassium channel, voltage gated subfamily E regulatory beta subunit 1
|
|
KCNH1
|
potassium channel, voltage gated eag related subfamily H, member 1
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ10
|
potassium channel, inwardly rectifying subfamily J, member 10
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNJ5
|
potassium channel, inwardly rectifying subfamily J, member 5
|
|
KCNK17
|
potassium channel, two pore domain subfamily K, member 17
|
|
KCNN3
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNQ2
|
potassium channel, voltage gated KQT-like subfamily Q, member 2
|
|
KCNT1
|
potassium channel, sodium activated subfamily T, member 1
|
|
KCTD12
|
potassium channel tetramerization domain containing 12
|
|
KCTD15
|
potassium channel tetramerization domain containing 15
|
|
KDM5A
|
lysine (K)-specific demethylase 5A
|
|
KDR
|
kinase insert domain receptor
|
|
KHDC3L
|
KH domain containing 3-like, subcortical maternal complex member
|
|
KIAA0196
|
KIAA0196
|
|
KIAA1524
|
KIAA1524
|
|
KIF11
|
kinesin family member 11
|
|
KIF21A
|
kinesin family member 21A
|
|
KIF21B
|
kinesin family member 21B
|
|
KIF6
|
kinesin family member 6
|
|
KIR2DL3
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3
|
|
KIR2DL5B
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5B
|
|
KIR2DS4
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4
|
|
KIR2DS5
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KIR3DS1
|
killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KL
|
klotho
|
|
KLHL10
|
kelch-like family member 10
|
|
KLK1
|
kallikrein 1
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLK4
|
kallikrein-related peptidase 4
|
|
KLKB1
|
kallikrein B, plasma (Fletcher factor) 1
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2C
|
lysine (K)-specific methyltransferase 2C
|
|
KNG1
|
kininogen 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRIT1
|
KRIT1, ankyrin repeat containing
|
|
KRT1
|
keratin 1, type II
|
|
KRT14
|
keratin 14, type I
|
|
KRT17
|
keratin 17, type I
|
|
KRT6A
|
keratin 6A, type II
|
|
KRT86
|
keratin 86, type II
|
|
KRT9
|
keratin 9, type I
|
|
KYNU
|
kynureninase
|
|
LAMA1
|
laminin, alpha 1
|
|
LAMP3
|
lysosomal-associated membrane protein 3
|
|
LAPTM4B
|
lysosomal protein transmembrane 4 beta
|
|
LBP
|
lipopolysaccharide binding protein
|
|
LBX1
|
ladybird homeobox 1
|
|
LCAT
|
lecithin-cholesterol acyltransferase
|
|
LCE3B
|
late cornified envelope 3B
|
|
LCE3C
|
late cornified envelope 3C
|
|
LCE3D
|
late cornified envelope 3D
|
|
LCN2
|
lipocalin 2
|
|
LCT
|
lactase
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGR4
|
leucine-rich repeat containing G protein-coupled receptor 4
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LHX1
|
LIM homeobox 1
|
|
LIG4
|
ligase IV, DNA, ATP-dependent
|
|
LINGO1
|
leucine rich repeat and Ig domain containing 1
|
|
LIPC
|
lipase, hepatic
|
|
LIPG
|
lipase, endothelial
|
|
LITAF
|
lipopolysaccharide-induced TNF factor
|
|
LMBR1
|
limb development membrane protein 1
|
|
LMNA
|
lamin A/C
|
|
LMX1A
|
LIM homeobox transcription factor 1, alpha
|
|
LMX1B
|
LIM homeobox transcription factor 1, beta
|
|
LOC728637
|
|
|
LOX
|
lysyl oxidase
|
|
LOXL1
|
lysyl oxidase-like 1
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LPAL2
|
lipoprotein, Lp(a)-like 2, pseudogene
|
|
LPAR6
|
lysophosphatidic acid receptor 6
|
|
LPIN1
|
lipin 1
|
|
LPL
|
lipoprotein lipase
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRP2
|
low density lipoprotein receptor-related protein 2
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LRP8
|
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor
|
|
LRRC4
|
leucine rich repeat containing 4
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LRRTM3
|
leucine rich repeat transmembrane neuronal 3
|
|
LSM1
|
LSM1, U6 small nuclear RNA associated
|
|
LTA
|
lymphotoxin alpha
|
|
LTA4H
|
leukotriene A4 hydrolase
|
|
LTBP2
|
latent transforming growth factor beta binding protein 2
|
|
LTC4S
|
leukotriene C4 synthase
|
|
LTF
|
lactotransferrin
|
|
LUM
|
lumican
|
|
LY6E
|
lymphocyte antigen 6 complex, locus E
|
|
LY96
|
lymphocyte antigen 96
|
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
|
|
MAG
|
myelin associated glycoprotein
|
|
MAMLD1
|
mastermind-like domain containing 1
|
|
MAN2A1
|
mannosidase, alpha, class 2A, member 1
|
|
MANBA
|
mannosidase, beta A, lysosomal
|
|
MAOA
|
monoamine oxidase A
|
|
MAOB
|
monoamine oxidase B
|
|
MAP4K5
|
mitogen-activated protein kinase kinase kinase kinase 5
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPT
|
microtubule-associated protein tau
|
|
MARCO
|
macrophage receptor with collagenous structure
|
|
MARK3
|
MAP/microtubule affinity-regulating kinase 3
|
|
MATN3
|
matrilin 3
|
|
MBD1
|
methyl-CpG binding domain protein 1
|
|
MBD4
|
methyl-CpG binding domain protein 4
|
|
MBD5
|
methyl-CpG binding domain protein 5
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MBP
|
myelin basic protein
|
|
MBTPS2
|
membrane-bound transcription factor peptidase, site 2
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCF2L2
|
MCF.2 cell line derived transforming sequence-like 2
|
|
MCM7
|
minichromosome maintenance complex component 7
|
|
MCPH1
|
microcephalin 1
|
|
MDGA1
|
MAM domain containing glycosylphosphatidylinositol anchor 1
|
|
MDGA2
|
MAM domain containing glycosylphosphatidylinositol anchor 2
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MED1
|
mediator complex subunit 1
|
|
MEF2A
|
myocyte enhancer factor 2A
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MEGF10
|
multiple EGF-like-domains 10
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MESP2
|
mesoderm posterior basic helix-loop-helix transcription factor 2
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFN2
|
mitofusin 2
|
|
MFSD2A
|
major facilitator superfamily domain containing 2A
|
|
MGP
|
matrix Gla protein
|
|
MGST2
|
microsomal glutathione S-transferase 2
|
|
MIA3
|
melanoma inhibitory activity family, member 3
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MINA
|
MYC induced nuclear antigen
|
|
MIP
|
major intrinsic protein of lens fiber
|
|
MIR100HG
|
mir-100-let-7a-2 cluster host gene
|
|
MIR106B
|
microRNA 106b
|
|
MIR124-1
|
microRNA 124-1
|
|
MIR135B
|
microRNA 135b
|
|
MIR137
|
microRNA 137
|
|
MIR143
|
microRNA 143
|
|
MIR146A
|
microRNA 146a
|
|
MIR148A
|
microRNA 148a
|
|
MIR155
|
microRNA 155
|
|
MIR181B1
|
microRNA 181b-1
|
|
MIR181B2
|
microRNA 181b-2
|
|
MIR196A1
|
microRNA 196a-1
|
|
MIR196A2
|
microRNA 196a-2
|
|
MIR20A
|
microRNA 20a
|
|
MIR21
|
microRNA 21
|
|
MIR218-1
|
microRNA 218-1
|
|
MIR27A
|
microRNA 27a
|
|
MIR27B
|
microRNA 27b
|
|
MIR31
|
microRNA 31
|
|
MIR335
|
microRNA 335
|
|
MIR34A
|
microRNA 34a
|
|
MIR34B
|
microRNA 34b
|
|
MIR34C
|
microRNA 34c
|
|
MIR375
|
microRNA 375
|
|
MIR499A
|
microRNA 499a
|
|
MIR502
|
microRNA 502
|
|
MIR7-1
|
microRNA 7-1
|
|
MIR7-2
|
microRNA 7-2
|
|
MIR7-3
|
microRNA 7-3
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MLC1
|
megalencephalic leukoencephalopathy with subcortical cysts 1
|
|
MLH1
|
mutL homolog 1
|
|
MLXIPL
|
MLX interacting protein-like
|
|
MMACHC
|
methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMEL1
|
membrane metallo-endopeptidase-like 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP11
|
matrix metallopeptidase 11
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP21
|
matrix metallopeptidase 21
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MN1
|
meningioma (disrupted in balanced translocation) 1
|
|
MNX1
|
motor neuron and pancreas homeobox 1
|
|
MOV10
|
Mov10 RISC complex RNA helicase
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MPO
|
myeloperoxidase
|
|
MPZL1
|
myelin protein zero-like 1
|
|
MRC1
|
mannose receptor, C type 1
|
|
MRPL3
|
mitochondrial ribosomal protein L3
|
|
MRPL4
|
mitochondrial ribosomal protein L4
|
|
MRPS30
|
mitochondrial ribosomal protein S30
|
|
MS4A2
|
membrane-spanning 4-domains, subfamily A, member 2
|
|
MS4A6A
|
membrane-spanning 4-domains, subfamily A, member 6A
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MSMB
|
microseminoprotein, beta-
|
|
MSR1
|
macrophage scavenger receptor 1
|
|
MSRA
|
methionine sulfoxide reductase A
|
|
MSTN
|
myostatin
|
|
MSX1
|
msh homeobox 1
|
|
MSX2
|
msh homeobox 2
|
|
MT-ATP6
|
ATP synthase F0 subunit 6
|
|
MT-ND3
|
NADH dehydrogenase, subunit 3 (complex I)
|
|
MT-ND4
|
NADH dehydrogenase, subunit 4 (complex I)
|
|
MT-ND5
|
NADH dehydrogenase, subunit 5 (complex I)
|
|
MT-ND6
|
NADH dehydrogenase, subunit 6 (complex I)
|
|
MT-TG
|
tRNA
|
|
MT-TM
|
tRNA
|
|
MT-TQ
|
tRNA
|
|
MTAP
|
methylthioadenosine phosphorylase
|
|
MTHFD1
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase
|
|
MTHFD1L
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTMR2
|
myotubularin related protein 2
|
|
MTMR3
|
myotubularin related protein 3
|
|
MTNR1A
|
melatonin receptor 1A
|
|
MTNR1B
|
melatonin receptor 1B
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
MTSS1
|
metastasis suppressor 1
|
|
MTTP
|
microsomal triglyceride transfer protein
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUTYH
|
mutY homolog
|
|
MVK
|
mevalonate kinase
|
|
MX1
|
MX dynamin-like GTPase 1
|
|
MXRA5
|
matrix-remodelling associated 5
|
|
MYBBP1A
|
MYB binding protein (P160) 1a
|
|
MYBPC3
|
myosin binding protein C, cardiac
|
|
MYCL
|
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog
|
|
MYH14
|
myosin, heavy chain 14, non-muscle
|
|
MYH7
|
myosin, heavy chain 7, cardiac muscle, beta
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYO1E
|
myosin IE
|
|
MYO5B
|
myosin VB
|
|
MYO7A
|
myosin VIIA
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
MYT1L
|
myelin transcription factor 1-like
|
|
N4BP2
|
NEDD4 binding protein 2
|
|
NAGLU
|
N-acetylglucosaminidase, alpha
|
|
NAIP
|
NLR family, apoptosis inhibitory protein
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NANOS3
|
nanos homolog 3 (Drosophila)
|
|
NAPG
|
N-ethylmaleimide-sensitive factor attachment protein, gamma
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NBN
|
nibrin
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCOA1
|
nuclear receptor coactivator 1
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCSTN
|
nicastrin
|
|
ND1
|
|
|
NDP
|
Norrie disease (pseudoglioma)
|
|
NDUFV2
|
NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa
|
|
NEDD4
|
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase
|
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase
|
|
NEDD9
|
neural precursor cell expressed, developmentally down-regulated 9
|
|
NEK2
|
NIMA-related kinase 2
|
|
NEUROD1
|
neuronal differentiation 1
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NGB
|
neuroglobin
|
|
NINJ2
|
ninjurin 2
|
|
NIPBL
|
Nipped-B homolog (Drosophila)
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NLGN3
|
neuroligin 3
|
|
NLGN4X
|
neuroligin 4, X-linked
|
|
NLRP1
|
NLR family, pyrin domain containing 1
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOBOX
|
NOBOX oogenesis homeobox
|
|
NOC3L
|
nucleolar complex associated 3 homolog (S. cerevisiae)
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NODAL
|
nodal growth differentiation factor
|
|
NOG
|
noggin
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS1AP
|
nitric oxide synthase 1 (neuronal) adaptor protein
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH3
|
notch 3
|
|
NOTCH4
|
notch 4
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NPC1L1
|
NPC1-like 1
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPA
|
natriuretic peptide A
|
|
NPPB
|
natriuretic peptide B
|
|
NPR2
|
natriuretic peptide receptor 2
|
|
NPR3
|
natriuretic peptide receptor 3
|
|
NPSR1
|
neuropeptide S receptor 1
|
|
NPY
|
neuropeptide Y
|
|
NPY2R
|
neuropeptide Y receptor Y2
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR2E3
|
nuclear receptor subfamily 2, group E, member 3
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRG1
|
neuregulin 1
|
|
NRG3
|
neuregulin 3
|
|
NRL
|
neural retina leucine zipper
|
|
NRP1
|
neuropilin 1
|
|
NRXN1
|
neurexin 1
|
|
NRXN3
|
neurexin 3
|
|
NTF4
|
neurotrophin 4
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NTSR1
|
neurotensin receptor 1 (high affinity)
|
|
NUDT1
|
nudix (nucleoside diphosphate linked moiety X)-type motif 1
|
|
NYX
|
nyctalopin
|
|
OAZ1
|
ornithine decarboxylase antizyme 1
|
|
OCA2
|
oculocutaneous albinism II
|
|
OCRL
|
oculocerebrorenal syndrome of Lowe
|
|
OFCC1
|
orofacial cleft 1 candidate 1
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OPTN
|
optineurin
|
|
ORMDL3
|
ORMDL sphingolipid biosynthesis regulator 3
|
|
OSBPL9
|
oxysterol binding protein-like 9
|
|
OTOF
|
otoferlin
|
|
OTX2
|
orthodenticle homeobox 2
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY1
|
purinergic receptor P2Y, G-protein coupled, 1
|
|
P2RY11
|
purinergic receptor P2Y, G-protein coupled, 11
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
P3H1
|
prolyl 3-hydroxylase 1
|
|
PABPN1
|
poly(A) binding protein, nuclear 1
|
|
PACRG
|
PARK2 co-regulated
|
|
PADI4
|
peptidyl arginine deiminase, type IV
|
|
PAFAH1B1
|
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa)
|
|
PAH
|
phenylalanine hydroxylase
|
|
PALB2
|
partner and localizer of BRCA2
|
|
PANK2
|
pantothenate kinase 2
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PARD3
|
par-3 family cell polarity regulator
|
|
PARK16
|
Parkinson disease 16 (susceptibility)
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK7
|
parkinson protein 7
|
|
PARL
|
presenilin associated, rhomboid-like
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX3
|
paired box 3
|
|
PAX4
|
paired box 4
|
|
PAX6
|
paired box 6
|
|
PAX7
|
paired box 7
|
|
PAX9
|
paired box 9
|
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
|
PCA3
|
prostate cancer associated 3 (non-protein coding)
|
|
PCDH11X
|
protocadherin 11 X-linked
|
|
PCDH19
|
protocadherin 19
|
|
PCK1
|
phosphoenolpyruvate carboxykinase 1 (soluble)
|
|
PCMT1
|
protein-L-isoaspartate (D-aspartate) O-methyltransferase
|
|
PCSK1
|
proprotein convertase subtilisin/kexin type 1
|
|
PCSK2
|
proprotein convertase subtilisin/kexin type 2
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD6IP
|
programmed cell death 6 interacting protein
|
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDE6B
|
phosphodiesterase 6B, cGMP-specific, rod, beta
|
|
PDE8B
|
phosphodiesterase 8B
|
|
PDGFD
|
platelet derived growth factor D
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDLIM5
|
PDZ and LIM domain 5
|
|
PDYN
|
prodynorphin
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PELP1
|
proline, glutamate and leucine rich protein 1
|
|
PEMT
|
phosphatidylethanolamine N-methyltransferase
|
|
PFN1
|
profilin 1
|
|
PGAM4
|
phosphoglycerate mutase family member 4
|
|
PGC
|
progastricsin (pepsinogen C)
|
|
PGR
|
progesterone receptor
|
|
PHEX
|
phosphate regulating endopeptidase homolog, X-linked
|
|
PHF11
|
PHD finger protein 11
|
|
PHLDB1
|
pleckstrin homology-like domain, family B, member 1
|
|
PHOX2B
|
paired-like homeobox 2b
|
|
PICALM
|
phosphatidylinositol binding clathrin assembly protein
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PIP4K2A
|
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha
|
|
PITX1
|
paired-like homeodomain 1
|
|
PITX2
|
paired-like homeodomain 2
|
|
PITX3
|
paired-like homeodomain 3
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PKP1
|
plakophilin 1
|
|
PKP2
|
plakophilin 2
|
|
PLA2G4C
|
phospholipase A2, group IVC (cytosolic, calcium-independent)
|
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLA2R1
|
phospholipase A2 receptor 1, 180kDa
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLCE1
|
phospholipase C, epsilon 1
|
|
PLEKHA7
|
pleckstrin homology domain containing, family A member 7
|
|
PLIN1
|
perilipin 1
|
|
PLOD1
|
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1
|
|
PLP1
|
proteolipid protein 1
|
|
PMEL
|
premelanosome protein
|
|
PML
|
promyelocytic leukemia
|
|
PMP22
|
peripheral myelin protein 22
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
PNMT
|
phenylethanolamine N-methyltransferase
|
|
PNPLA2
|
patatin-like phospholipase domain containing 2
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
POLE
|
polymerase (DNA directed), epsilon, catalytic subunit
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
POMC
|
proopiomelanocortin
|
|
POMGNT1
|
protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)
|
|
PON1
|
paraoxonase 1
|
|
PON2
|
paraoxonase 2
|
|
POR
|
P450 (cytochrome) oxidoreductase
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
POU3F4
|
POU class 3 homeobox 4
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
POU5F1B
|
POU class 5 homeobox 1B
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPARGC1B
|
peroxisome proliferator-activated receptor gamma, coactivator 1 beta
|
|
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like
|
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B
|
|
PPP1R3A
|
protein phosphatase 1, regulatory subunit 3A
|
|
PPP1R3B
|
protein phosphatase 1, regulatory subunit 3B
|
|
PPP2R1A
|
protein phosphatase 2, regulatory subunit A, alpha
|
|
PPP2R5E
|
protein phosphatase 2, regulatory subunit B', epsilon isoform
|
|
PRCP
|
prolylcarboxypeptidase (angiotensinase C)
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRDM16
|
PR domain containing 16
|
|
PRDM9
|
PR domain containing 9
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
|
PRKAG2
|
protein kinase, AMP-activated, gamma 2 non-catalytic subunit
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCH
|
protein kinase C, eta
|
|
PRKCI
|
protein kinase C, iota
|
|
PRM1
|
protamine 1
|
|
PRND
|
prion protein 2 (dublet)
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROCR
|
protein C receptor, endothelial
|
|
PROM1
|
prominin 1
|
|
PROS1
|
protein S (alpha)
|
|
PRPF31
|
pre-mRNA processing factor 31
|
|
PRPH2
|
peripherin 2 (retinal degeneration, slow)
|
|
PRRC2A
|
proline-rich coiled-coil 2A
|
|
PRRT2
|
proline-rich transmembrane protein 2
|
|
PRSS1
|
protease, serine, 1 (trypsin 1)
|
|
PSCA
|
prostate stem cell antigen
|
|
PSEN1
|
presenilin 1
|
|
PSEN2
|
presenilin 2
|
|
PSENEN
|
presenilin enhancer gamma secretase subunit
|
|
PSMA6
|
proteasome (prosome, macropain) subunit, alpha type, 6
|
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9
|
|
PSMD7
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 7
|
|
PSORS1C2
|
psoriasis susceptibility 1 candidate 2
|
|
PSORS4
|
psoriasis susceptibility 4
|
|
PSORS9
|
psoriasis susceptibility 9
|
|
PTCH1
|
patched 1
|
|
PTCH2
|
patched 2
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDR
|
prostaglandin D2 receptor (DP)
|
|
PTGDR2
|
prostaglandin D2 receptor 2
|
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain)
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGIS
|
prostaglandin I2 (prostacyclin) synthase
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN13
|
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPRD
|
protein tyrosine phosphatase, receptor type, D
|
|
PTS
|
6-pyruvoyltetrahydropterin synthase
|
|
PXK
|
PX domain containing serine/threonine kinase
|
|
QKI
|
QKI, KH domain containing, RNA binding
|
|
QPCT
|
glutaminyl-peptide cyclotransferase
|
|
RAB29
|
RAB29, member RAS oncogene family
|
|
RAB3A
|
RAB3A, member RAS oncogene family
|
|
RAB7A
|
RAB7A, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD50
|
RAD50 homolog (S. cerevisiae)
|
|
RAD52
|
RAD52 homolog (S. cerevisiae)
|
|
RAD54B
|
RAD54 homolog B (S. cerevisiae)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAG1
|
recombination activating gene 1
|
|
RAPGEF6
|
Rap guanine nucleotide exchange factor (GEF) 6
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RARB
|
retinoic acid receptor, beta
|
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
|
RASAL1
|
RAS protein activator like 1 (GAP1 like)
|
|
RASGRP1
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated)
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RDH8
|
retinol dehydrogenase 8 (all-trans)
|
|
RECQL5
|
RecQ protein-like 5
|
|
REEP1
|
receptor accessory protein 1
|
|
RELN
|
reelin
|
|
REN
|
renin
|
|
RENBP
|
renin binding protein
|
|
REST
|
RE1-silencing transcription factor
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
REV3L
|
REV3-like, polymerase (DNA directed), zeta, catalytic subunit
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RGS4
|
regulator of G-protein signaling 4
|
|
RHD
|
Rh blood group, D antigen
|
|
RHO
|
rhodopsin
|
|
RHOA
|
ras homolog family member A
|
|
RHOBTB2
|
Rho-related BTB domain containing 2
|
|
RHOC
|
ras homolog family member C
|
|
RIC3
|
RIC3 acetylcholine receptor chaperone
|
|
RIPK2
|
receptor-interacting serine-threonine kinase 2
|
|
RNF114
|
ring finger protein 114
|
|
RNF213
|
ring finger protein 213
|
|
RNF41
|
ring finger protein 41, E3 ubiquitin protein ligase
|
|
RNF43
|
ring finger protein 43
|
|
RNLS
|
renalase, FAD-dependent amine oxidase
|
|
RNR1
|
RNA, ribosomal cluster 1
|
|
ROR2
|
receptor tyrosine kinase-like orphan receptor 2
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
|
RP1
|
retinitis pigmentosa 1 (autosomal dominant)
|
|
RP2
|
retinitis pigmentosa 2 (X-linked recessive)
|
|
RPE65
|
retinal pigment epithelium-specific protein 65kDa
|
|
RPGR
|
retinitis pigmentosa GTPase regulator
|
|
RPLP0
|
ribosomal protein, large, P0
|
|
RPLP1
|
ribosomal protein, large, P1
|
|
RPLP2
|
ribosomal protein, large, P2
|
|
RS1
|
retinoschisin 1
|
|
RTEL1
|
regulator of telomere elongation helicase 1
|
|
RTN4
|
reticulon 4
|
|
RTN4R
|
reticulon 4 receptor
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RXRA
|
retinoid X receptor, alpha
|
|
RYBP
|
RING1 and YY1 binding protein
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S100B
|
S100 calcium binding protein B
|
|
SAA1
|
serum amyloid A1
|
|
SAA2
|
serum amyloid A2
|
|
SACK1H
|
scaffolding CK1 anchoring protein H
|
|
SAG
|
S-antigen; retina and pineal gland (arrestin)
|
|
SALL4
|
spalt-like transcription factor 4
|
|
SART3
|
squamous cell carcinoma antigen recognized by T cells 3
|
|
SC5D
|
sterol-C5-desaturase
|
|
SCAP
|
SREBF chaperone
|
|
SCARB2
|
scavenger receptor class B, member 2
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SCGB3A2
|
secretoglobin, family 3A, member 2
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCN4A
|
sodium channel, voltage gated, type IV alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCN8A
|
sodium channel, voltage gated, type VIII alpha subunit
|
|
SCNN1A
|
sodium channel, non voltage gated 1 alpha subunit
|
|
SCNN1B
|
sodium channel, non voltage gated 1 beta subunit
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
|
SEC16B
|
SEC16 homolog B (S. cerevisiae)
|
|
SELE
|
selectin E
|
|
SELL
|
selectin L
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
|
|
SEMA5A
|
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A
|
|
SEPT9
|
septin 9
|
|
SERPINA12
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12
|
|
SERPINA13P
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 13, pseudogene
|
|
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
|
|
SERPINA6
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6
|
|
SERPINB7
|
serpin peptidase inhibitor, clade B (ovalbumin), member 7
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
|
SETD8
|
SET domain containing (lysine methyltransferase) 8
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFRP5
|
secreted frizzled-related protein 5
|
|
SFTPA1
|
surfactant protein A1
|
|
SFTPA2
|
surfactant protein A2
|
|
SFTPB
|
surfactant protein B
|
|
SFTPD
|
surfactant protein D
|
|
SGCE
|
sarcoglycan, epsilon
|
|
SH2B1
|
SH2B adaptor protein 1
|
|
SH2D1A
|
SH2 domain containing 1A
|
|
SH3BP2
|
SH3-domain binding protein 2
|
|
SHANK2
|
SH3 and multiple ankyrin repeat domains 2
|
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3
|
|
SHBG
|
sex hormone-binding globulin
|
|
SIAH2
|
siah E3 ubiquitin protein ligase 2
|
|
SIM2
|
single-minded family bHLH transcription factor 2
|
|
SIRT1
|
sirtuin 1
|
|
SIRT2
|
sirtuin 2
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1
|
|
SLC11A2
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2
|
|
SLC12A3
|
solute carrier family 12 (sodium/chloride transporter), member 3
|
|
SLC15A2
|
solute carrier family 15 (oligopeptide transporter), member 2
|
|
SLC15A4
|
solute carrier family 15 (oligopeptide transporter), member 4
|
|
SLC16A4
|
solute carrier family 16, member 4
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC19A2
|
solute carrier family 19 (thiamine transporter), member 2
|
|
SLC1A1
|
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1
|
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2
|
|
SLC22A12
|
solute carrier family 22 (organic anion/urate transporter), member 12
|
|
SLC22A2
|
solute carrier family 22 (organic cation transporter), member 2
|
|
SLC22A3
|
solute carrier family 22 (organic cation transporter), member 3
|
|
SLC22A4
|
solute carrier family 22 (organic cation/zwitterion transporter), member 4
|
|
SLC22A5
|
solute carrier family 22 (organic cation/carnitine transporter), member 5
|
|
SLC25A13
|
solute carrier family 25 (aspartate/glutamate carrier), member 13
|
|
SLC25A38
|
solute carrier family 25, member 38
|
|
SLC26A2
|
solute carrier family 26 (anion exchanger), member 2
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SLC2A14
|
solute carrier family 2 (facilitated glucose transporter), member 14
|
|
SLC2A2
|
solute carrier family 2 (facilitated glucose transporter), member 2
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC2A9
|
solute carrier family 2 (facilitated glucose transporter), member 9
|
|
SLC30A2
|
solute carrier family 30 (zinc transporter), member 2
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
|
SLC34A2
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 2
|
|
SLC41A1
|
solute carrier family 41 (magnesium transporter), member 1
|
|
SLC44A2
|
solute carrier family 44 (choline transporter), member 2
|
|
SLC45A2
|
solute carrier family 45, member 2
|
|
SLC45A3
|
solute carrier family 45, member 3
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3
|
|
SLCO2A1
|
solute carrier organic anion transporter family, member 2A1
|
|
SLIT3
|
slit homolog 3 (Drosophila)
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD7
|
SMAD family member 7
|
|
SMARCAL1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SMN2
|
survival of motor neuron 2, centromeric
|
|
SMPD1
|
sphingomyelin phosphodiesterase 1, acid lysosomal
|
|
SMYD3
|
SET and MYND domain containing 3
|
|
SNAP25
|
synaptosomal-associated protein, 25kDa
|
|
SNAPC4
|
small nuclear RNA activating complex, polypeptide 4, 190kDa
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1)
|
|
SNRNP200
|
small nuclear ribonucleoprotein 200kDa (U5)
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOHLH2
|
spermatogenesis and oogenesis specific basic helix-loop-helix 2
|
|
SORCS1
|
sortilin-related VPS10 domain containing receptor 1
|
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing
|
|
SORT1
|
sortilin 1
|
|
SOST
|
sclerostin
|
|
SOSTDC1
|
sclerostin domain containing 1
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX5
|
SRY (sex determining region Y)-box 5
|
|
SOX6
|
SRY (sex determining region Y)-box 6
|
|
SP110
|
SP110 nuclear body protein
|
|
SP3
|
Sp3 transcription factor
|
|
SP8
|
Sp8 transcription factor
|
|
SPAST
|
spastin
|
|
SPATA7
|
spermatogenesis associated 7
|
|
SPG11
|
spastic paraplegia 11 (autosomal recessive)
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SPINK5
|
serine peptidase inhibitor, Kazal type 5
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SQSTM1
|
sequestosome 1
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SREBF2
|
sterol regulatory element binding transcription factor 2
|
|
SRR
|
serine racemase
|
|
SSH1
|
slingshot protein phosphatase 1
|
|
SST
|
somatostatin
|
|
ST8SIA2
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2
|
|
STAB1
|
stabilin 1
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STEAP4
|
STEAP family member 4
|
|
STK11
|
serine/threonine kinase 11
|
|
STK39
|
serine threonine kinase 39
|
|
STMN1
|
stathmin 1
|
|
STON2
|
stonin 2
|
|
STX11
|
syntaxin 11
|
|
SULT1A1
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1
|
|
SUMO4
|
small ubiquitin-like modifier 4
|
|
SUSD2
|
sushi domain containing 2
|
|
SUSD4
|
sushi domain containing 4
|
|
SYN2
|
synapsin II
|
|
SYN3
|
synapsin III
|
|
SYNGR1
|
synaptogyrin 1
|
|
TAC1
|
tachykinin, precursor 1
|
|
TACR1
|
tachykinin receptor 1
|
|
TACR2
|
tachykinin receptor 2
|
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TARDBP
|
TAR DNA binding protein
|
|
TBC1D22A
|
TBC1 domain family, member 22A
|
|
TBKBP1
|
TBK1 binding protein 1
|
|
TBX1
|
T-box 1
|
|
TBX21
|
T-box 21
|
|
TBX5
|
T-box 5
|
|
TBX6
|
T-box 6
|
|
TCF4
|
transcription factor 4
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TCN2
|
transcobalamin II
|
|
TCOF1
|
Treacher Collins-Franceschetti syndrome 1
|
|
TDRD7
|
tudor domain containing 7
|
|
TDRP
|
testis development related protein
|
|
TEF
|
thyrotrophic embryonic factor
|
|
TERC
|
telomerase RNA component
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TEX15
|
testis expressed 15
|
|
TF
|
transferrin
|
|
TFAM
|
transcription factor A, mitochondrial
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFAP2B
|
transcription factor AP-2 beta (activating enhancer binding protein 2 beta)
|
|
TFAP4
|
transcription factor AP-4 (activating enhancer binding protein 4)
|
|
TFF2
|
trefoil factor 2
|
|
TFF3
|
trefoil factor 3 (intestinal)
|
|
TFR2
|
transferrin receptor 2
|
|
TG
|
thyroglobulin
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGFBR3
|
transforming growth factor, beta receptor III
|
|
TH
|
tyrosine hydroxylase
|
|
THADA
|
thyroid adenoma associated
|
|
THAP1
|
THAP domain containing, apoptosis associated protein 1
|
|
THBS1
|
thrombospondin 1
|
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1
|
|
TIMD4
|
T-cell immunoglobulin and mucin domain containing 4
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TIMP4
|
TIMP metallopeptidase inhibitor 4
|
|
TIRAP
|
toll-interleukin 1 receptor (TIR) domain containing adaptor protein
|
|
TLL1
|
tolloid-like 1
|
|
TLR10
|
toll-like receptor 10
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR6
|
toll-like receptor 6
|
|
TLR7
|
toll-like receptor 7
|
|
TLR9
|
toll-like receptor 9
|
|
TMEM106B
|
transmembrane protein 106B
|
|
TMEM121
|
transmembrane protein 121
|
|
TMEM18
|
transmembrane protein 18
|
|
TMPRSS6
|
transmembrane protease, serine 6
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFAIP8
|
tumor necrosis factor, alpha-induced protein 8
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
|
TNIP1
|
TNFAIP3 interacting protein 1
|
|
TNNI2
|
troponin I type 2 (skeletal, fast)
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TOLLIP
|
toll interacting protein
|
|
TOMM40
|
translocase of outer mitochondrial membrane 40 homolog (yeast)
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
|
TOX3
|
TOX high mobility group box family member 3
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
TPMT
|
thiopurine S-methyltransferase
|
|
TPO
|
thyroid peroxidase
|
|
TRA
|
T cell receptor alpha locus
|
|
TRAF3
|
TNF receptor-associated factor 3
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRAPPC2
|
trafficking protein particle complex 2
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
|
TREM2
|
triggering receptor expressed on myeloid cells 2
|
|
TRIB3
|
tribbles pseudokinase 3
|
|
TRIM5
|
tripartite motif containing 5
|
|
TRPC1
|
transient receptor potential cation channel, subfamily C, member 1
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TRPM5
|
transient receptor potential cation channel, subfamily M, member 5
|
|
TRPM6
|
transient receptor potential cation channel, subfamily M, member 6
|
|
TRPS1
|
trichorhinophalangeal syndrome I
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TSNAX
|
translin-associated factor X
|
|
TSPAN18
|
tetraspanin 18
|
|
TTBK1
|
tau tubulin kinase 1
|
|
TTR
|
transthyretin
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TYK2
|
tyrosine kinase 2
|
|
TYMP
|
thymidine phosphorylase
|
|
TYMS
|
thymidylate synthetase
|
|
TYR
|
tyrosinase
|
|
TYRP1
|
tyrosinase-related protein 1
|
|
UBAC2
|
UBA domain containing 2
|
|
UBE2B
|
ubiquitin-conjugating enzyme E2B
|
|
UBE2L3
|
ubiquitin-conjugating enzyme E2L 3
|
|
UBIAD1
|
UbiA prenyltransferase domain containing 1
|
|
UBQLN1
|
ubiquilin 1
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UCP1
|
uncoupling protein 1 (mitochondrial, proton carrier)
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UCP3
|
uncoupling protein 3 (mitochondrial, proton carrier)
|
|
UGT1A
|
UDP glucuronosyltransferase 1 family, polypeptide A complex locus
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT1A4
|
UDP glucuronosyltransferase 1 family, polypeptide A4
|
|
UGT1A7
|
UDP glucuronosyltransferase 1 family, polypeptide A7
|
|
UGT1A8
|
UDP glucuronosyltransferase 1 family, polypeptide A8
|
|
UGT1A9
|
UDP glucuronosyltransferase 1 family, polypeptide A9
|
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
|
UMOD
|
uromodulin
|
|
UMODL1
|
uromodulin-like 1
|
|
UNC13D
|
unc-13 homolog D (C. elegans)
|
|
UROD
|
uroporphyrinogen decarboxylase
|
|
USH2A
|
Usher syndrome 2A (autosomal recessive, mild)
|
|
USP24
|
ubiquitin specific peptidase 24
|
|
USP40
|
ubiquitin specific peptidase 40
|
|
USP9Y
|
ubiquitin specific peptidase 9, Y-linked
|
|
UTS2
|
urotensin 2
|
|
UTS2B
|
urotensin 2B
|
|
VAMP8
|
vesicle-associated membrane protein 8
|
|
VCP
|
valosin containing protein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VIMP
|
VCP-interacting membrane selenoprotein
|
|
VIP
|
vasoactive intestinal peptide
|
|
VIPR2
|
vasoactive intestinal peptide receptor 2
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VPS33B
|
vacuolar protein sorting 33 homolog B (yeast)
|
|
VPS35
|
vacuolar protein sorting 35 homolog (S. cerevisiae)
|
|
VRK1
|
vaccinia related kinase 1
|
|
VRK2
|
vaccinia related kinase 2
|
|
VSX1
|
visual system homeobox 1
|
|
VTCN1
|
V-set domain containing T cell activation inhibitor 1
|
|
VTN
|
vitronectin
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
|
WISP3
|
WNT1 inducible signaling pathway protein 3
|
|
WNT10A
|
wingless-type MMTV integration site family, member 10A
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WNT4
|
wingless-type MMTV integration site family, member 4
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WNT7A
|
wingless-type MMTV integration site family, member 7A
|
|
WNT9B
|
wingless-type MMTV integration site family, member 9B
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WT1
|
Wilms tumor 1
|
|
WWC1
|
WW and C2 domain containing 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPA
|
xeroderma pigmentosum, complementation group A
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
XRCC4
|
X-ray repair complementing defective repair in Chinese hamster cells 4
|
|
XRCC5
|
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
|
|
XRCC6
|
X-ray repair complementing defective repair in Chinese hamster cells 6
|
|
XYLT2
|
xylosyltransferase II
|
|
YWHAE
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon
|
|
ZBTB12
|
zinc finger and BTB domain containing 12
|
|
ZBTB17
|
zinc finger and BTB domain containing 17
|
|
ZBTB38
|
zinc finger and BTB domain containing 38
|
|
ZDHHC8
|
zinc finger, DHHC-type containing 8
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZFHX3
|
zinc finger homeobox 3
|
|
ZG16B
|
zymogen granule protein 16B
|
|
ZNF350
|
zinc finger protein 350
|
|
ZNF510
|
zinc finger protein 510
|
|
ZNF644
|
zinc finger protein 644
|
|
ZNF652
|
zinc finger protein 652
|
|
ZNF782
|
zinc finger protein 782
|
|
ZNF804A
|
zinc finger protein 804A
|
|
ZNRD1
|
zinc ribbon domain containing 1
|
